Andreas Linderoth Norlin

Membre du Conseil

BoardM

FI·FIN-FSA

Ascelia Pharma AB Ascelia Pharma AB

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the detailed record of transactions filed by Andreas Linderoth Norlin, Membre du Conseil. Director active across 2 companies, notably Ascelia Pharma AB. Cumulatively, 1 disclosures have been recorded. The latest transaction was filed on 25 November 2025 — Purchase. Regulator: FIN-FSA. The full history is openly available.

Declarations1 total

Executives●PurchaseAAscelia Pharma AB13FIN-FSA

A

Andreas Linderoth NorlinAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan

01,754 shares0

Aktie

FI:A003U157-1·25 Nov 2025

Ideal exit: 22 Aug 2026 (T+270)

FIN-FSA ↗

1 of 1 declaration

About Andreas Linderoth Norlin

Andreas Linderoth Norlin is a board member of Ascelia Pharma AB. He participates in strategic decisions and the governance of the company. Ascelia Pharma AB is a company specializing in drug development.